- Corporate Officers - H
- Hbm Healthcare Investments (cayman) Ltd.
Insider Trading History of Hbm Healthcare Investments (cayman) Ltd.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hbm Healthcare Investments (cayman) Ltd. since 2005.
This trader's CIK number is 1232258.
At the time of last reporting, Hbm Healthcare Investments (cayman) Ltd. was the Officer of Mineralys Therapeutics, Inc.. (stock ticker symbol MLYS).
Also see all insider trading activities at Mineralys Therapeutics, Inc..
Note that in the past
HBM Healthcare Investments (Cayman) Ltd. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Mineralys Therapeutics, Inc. (MLYS) by Hbm Healthcare Investments (cayman) Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | MLYS | 312,500 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Micrus Endovascular Corp (MEND) by Hbm Healthcare Investments (cayman) Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | MEND | 0 | $0 | 204,336 | $4,195,941 | 0 | $0 |
| 2009 | MEND | 0 | $0 | 167,200 | $1,844,112 | 0 | $0 |
| 2008 | MEND | 246,500 | $3,447,661 | 0 | $0 | 0 | $0 |
| 2007 | MEND | 0 | $0 | 188,322 | $4,472,430 | 0 | $0 |
Yearly summary of insider trading at Nabriva Therapeutics Plc (NBRV) by Hbm Healthcare Investments (cayman) Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | NBRV | 0 | $0 | 173,955 | $1,829,125 | 0 | $0 |
Yearly summary of insider trading at Paratek Pharmaceuticals, Inc. (PRTK) by Hbm Healthcare Investments (cayman) Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | PRTK | 0 | $0 | 20,580 | $635,706 | 0 | $0 |
Yearly summary of insider trading at Iveric Bio, Inc. (OPHT) by Hbm Healthcare Investments (cayman) Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | OPHT | 0 | $0 | 500,000 | $14,875,000 | 0 | $0 |
| 2013 | OPHT | 228,000 | $5,016,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Ptc Therapeutics, Inc. (PTCT) by Hbm Healthcare Investments (cayman) Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | PTCT | 666,676 | $10,000,140 | 66,667 | $1,272,139 | 0 | $0 |
Yearly summary of insider trading at Aspreva Pharmaceuticals Corp (ASPV) by Hbm Healthcare Investments (cayman) Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2005 | ASPV | 498,215 | $7,650,395 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pacira Biosciences, Inc. (PCRX) by Hbm Healthcare Investments (cayman) Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | PCRX | 0 | $0 | 1,200,000 | $33,591,761 | 0 | $0 |
| 2011 | PCRX | 843,406 | $5,749,996 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Io Biotech, Inc. (IOBT) by Hbm Healthcare Investments (cayman) Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | IOBT | 325,000 | $4,550,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Nabriva Therapeutics Plc (NBRV) by Hbm Healthcare Investments (cayman) Ltd.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | NBRV | 0 | $0 | 296,029 | $3,137,968 | 0 | $0 |
Insider trading activities at 10 companies by Hbm Healthcare Investments (cayman) Ltd.:
1. Mineralys Therapeutics, Inc. (MLYS)
2. Micrus Endovascular Corp (MEND)
3. Nabriva Therapeutics Plc (NBRV)
4. Paratek Pharmaceuticals, Inc. (PRTK)
5. Iveric Bio, Inc. (OPHT)
6. Ptc Therapeutics, Inc. (PTCT)
7. Aspreva Pharmaceuticals Corp (ASPV)
8. Pacira Biosciences, Inc. (PCRX)
9. Io Biotech, Inc. (IOBT)
10. Nabriva Therapeutics Plc (NBRV)
Table 1. Insider trading of Mineralys Therapeutics, Inc. (MLYS) by Hbm Healthcare Investments (cayman) Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-02-14 | MLYS | Buy | 312,500 | 16.00 | 5,000,000 |
Table 2. Insider trading of Micrus Endovascular Corp (MEND) by Hbm Healthcare Investments (cayman) Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-03-02 | MEND | Sale | 46,196 | 21.15 | 976,860 |
| 2010-03-03 | MEND | Sale | 21,200 | 20.98 | 444,691 |
| 2010-02-23 | MEND | Sale | 40,000 | 20.02 | 800,680 |
| 2010-02-24 | MEND | Sale | 30,000 | 19.93 | 598,050 |
| 2010-02-22 | MEND | Sale | 65,000 | 20.52 | 1,333,605 |
| 2010-02-19 | MEND | Sale | 1,940 | 21.68 | 42,055 |
| 2009-08-13 | MEND | Sale | 25,000 | 11.05 | 276,250 |
| 2009-08-12 | MEND | Sale | 50,000 | 11.10 | 555,150 |
| 2009-08-11 | MEND | Sale | 43,900 | 10.96 | 481,012 |
| 2009-08-10 | MEND | Sale | 2,200 | 11.21 | 24,657 |
| 2009-08-10 | MEND | Sale | 21,100 | 11.09 | 233,893 |
| 2009-08-07 | MEND | Sale | 25,000 | 10.93 | 273,150 |
| 2008-06-20 | MEND | Buy | 17,741 | 13.75 | 243,921 |
| 2008-06-19 | MEND | Buy | 3,459 | 13.58 | 46,966 |
| 2008-06-17 | MEND | Buy | 3,800 | 13.54 | 51,455 |
| 2008-06-06 | MEND | Buy | 15,000 | 12.24 | 183,675 |
| 2008-06-05 | MEND | Buy | 30,000 | 12.19 | 365,700 |
| 2008-02-15 | MEND | Buy | 7,700 | 13.92 | 107,199 |
| 2008-02-12 | MEND | Buy | 29,900 | 14.57 | 435,732 |
| 2008-02-14 | MEND | Buy | 22,800 | 14.31 | 326,268 |
| 2008-02-14 | MEND | Buy | 23,600 | 14.13 | 333,444 |
| 2008-02-13 | MEND | Buy | 50,100 | 14.54 | 728,604 |
| 2008-02-12 | MEND | Buy | 32,500 | 14.81 | 481,455 |
| 2008-02-13 | MEND | Buy | 7,700 | 14.39 | 110,810 |
| 2008-02-13 | MEND | Buy | 2,200 | 14.74 | 32,432 |
| 2007-08-22 | MEND | Sale | 1,100 | 23.29 | 25,614 |
| 2007-08-20 | MEND | Sale | 3,500 | 23.41 | 81,952 |
| 2007-08-21 | MEND | Sale | 1,635 | 23.28 | 38,066 |
| 2007-08-21 | MEND | Sale | 7,400 | 23.14 | 171,236 |
| 2007-08-20 | MEND | Sale | 5,700 | 23.18 | 132,114 |
| 2007-08-17 | MEND | Sale | 3,122 | 23.70 | 73,982 |
| 2007-08-17 | MEND | Sale | 38,304 | 23.17 | 887,503 |
| 2007-02-07 | MEND | Sale | 9,756 | 24.00 | 234,144 |
| 2007-02-06 | MEND | Sale | 4,655 | 24.00 | 111,720 |
| 2007-02-05 | MEND | Sale | 49,978 | 24.01 | 1,199,971 |
| 2007-01-31 | MEND | Sale | 20,300 | 24.00 | 487,200 |
| 2007-02-02 | MEND | Sale | 32,628 | 24.00 | 783,072 |
| 2007-02-09 | MEND | Sale | 10,244 | 24.00 | 245,856 |
Table 3. Insider trading of Nabriva Therapeutics Plc (NBRV) by Hbm Healthcare Investments (cayman) Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-07-19 | NBRV | Sale | 20,786 | 10.50 | 218,253 |
| 2017-07-20 | NBRV | Sale | 23,445 | 10.50 | 246,172 |
| 2017-07-17 | NBRV | Sale | 47,460 | 10.50 | 498,424 |
| 2017-07-14 | NBRV | Sale | 21,055 | 10.53 | 221,793 |
| 2017-07-18 | NBRV | Sale | 1,339 | 10.50 | 14,059 |
| 2017-07-12 | NBRV | Sale | 13,740 | 10.50 | 144,270 |
| 2017-07-13 | NBRV | Sale | 39,914 | 10.54 | 420,773 |
| 2017-07-11 | NBRV | Sale | 3,521 | 10.52 | 37,026 |
| 2017-07-05 | NBRV | Sale | 2,562 | 10.52 | 26,959 |
| 2017-07-07 | NBRV | Sale | 133 | 10.50 | 1,396 |
Table 4. Insider trading of Paratek Pharmaceuticals, Inc. (PRTK) by Hbm Healthcare Investments (cayman) Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-05-29 | PRTK | Sale | 10,000 | 29.89 | 298,860 |
| 2015-05-28 | PRTK | Sale | 10,580 | 31.84 | 336,846 |
Table 5. Insider trading of Iveric Bio, Inc. (OPHT) by Hbm Healthcare Investments (cayman) Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-05-13 | OPHT | Sale | 500,000 | 29.75 | 14,875,000 |
| 2013-09-30 | OPHT | Buy | 228,000 | 22.00 | 5,016,000 |
Table 6. Insider trading of Ptc Therapeutics, Inc. (PTCT) by Hbm Healthcare Investments (cayman) Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-12-17 | PTCT | Sale | 66,667 | 19.08 | 1,272,139 |
| 2013-06-25 | PTCT | Buy | 666,676 | 15.00 | 10,000,140 |
Table 7. Insider trading of Aspreva Pharmaceuticals Corp (ASPV) by Hbm Healthcare Investments (cayman) Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2005-03-16 | ASPV | Buy | 32,215 | 12.83 | 413,415 |
| 2005-03-09 | ASPV | Buy | 466,000 | 15.53 | 7,236,980 |
Table 8. Insider trading of Pacira Biosciences, Inc. (PCRX) by Hbm Healthcare Investments (cayman) Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-03-21 | PCRX | Sale | 11,431 | 27.50 | 314,352 |
| 2013-03-22 | PCRX | Sale | 113,928 | 27.52 | 3,135,640 |
| 2013-03-25 | PCRX | Sale | 165,541 | 28.27 | 4,680,671 |
| 2013-03-18 | PCRX | Sale | 400,000 | 28.19 | 11,277,600 |
| 2013-03-19 | PCRX | Sale | 9,100 | 27.86 | 253,498 |
| 2013-03-11 | PCRX | Sale | 500,000 | 27.86 | 13,930,000 |
| 2011-11-21 | PCRX | Buy | 307,692 | 6.50 | 1,999,998 |
| 2011-02-08 | PCRX | Buy | 535,714 | 7.00 | 3,749,998 |
Table 9. Insider trading of Io Biotech, Inc. (IOBT) by Hbm Healthcare Investments (cayman) Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-11-09 | IOBT | Buy | 325,000 | 14.00 | 4,550,000 |
Table 10. Insider trading of Nabriva Therapeutics Plc (NBRV) by Hbm Healthcare Investments (cayman) Ltd.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-09-12 | NBRV | Sale | 10,458 | 8.63 | 90,231 |
| 2017-09-13 | NBRV | Sale | 22,721 | 8.54 | 193,946 |
| 2017-09-14 | NBRV | Sale | 3,429 | 8.52 | 29,225 |
| 2017-08-31 | NBRV | Sale | 639 | 9.50 | 6,070 |
| 2017-08-07 | NBRV | Sale | 17,790 | 10.50 | 186,795 |
| 2017-08-08 | NBRV | Sale | 2,013 | 10.50 | 21,136 |
| 2017-07-28 | NBRV | Sale | 6,585 | 10.51 | 69,195 |
| 2017-07-24 | NBRV | Sale | 160 | 10.50 | 1,680 |
| 2017-07-20 | NBRV | Sale | 23,445 | 10.50 | 246,172 |
| 2017-07-19 | NBRV | Sale | 20,786 | 10.50 | 218,253 |
| 2017-07-03 | NBRV | Sale | 11,352 | 10.95 | 124,247 |
| 2017-06-30 | NBRV | Sale | 1,775 | 10.94 | 19,420 |
| 2017-06-27 | NBRV | Sale | 2,166 | 10.83 | 23,457 |
| 2017-06-28 | NBRV | Sale | 4,789 | 11.10 | 53,157 |
| 2017-06-29 | NBRV | Sale | 1,603 | 10.72 | 17,188 |
| 2017-06-01 | NBRV | Sale | 400 | 11.27 | 4,508 |
| 2017-04-28 | NBRV | Sale | 15,130 | 11.03 | 166,808 |
| 2017-04-27 | NBRV | Sale | 100 | 11.00 | 1,100 |
| 2017-04-26 | NBRV | Sale | 709 | 11.00 | 7,799 |
| 2017-04-21 | NBRV | Sale | 2,622 | 11.04 | 28,936 |
| 2017-04-18 | NBRV | Sale | 11,822 | 11.16 | 131,886 |
| 2017-04-19 | NBRV | Sale | 11,785 | 11.07 | 130,436 |
| 2017-04-20 | NBRV | Sale | 325 | 11.00 | 3,575 |
| 2017-04-13 | NBRV | Sale | 10,984 | 11.13 | 122,229 |
| 2017-04-12 | NBRV | Sale | 13,250 | 11.22 | 148,651 |
| 2017-04-11 | NBRV | Sale | 8,597 | 11.40 | 98,031 |
| 2017-04-06 | NBRV | Sale | 31,217 | 11.24 | 350,879 |
| 2017-04-07 | NBRV | Sale | 21,501 | 11.00 | 236,511 |
| 2017-04-10 | NBRV | Sale | 37,876 | 10.73 | 406,447 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Hbm Healthcare Investments (cayman) Ltd.
(Officer of Mineralys Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.